Force17

Here are 4 key messages of #FORCE17, which held its 10^th anniversary conference last week on hereditary cancer issues.

1. One-step and done? Nearly all breast reconstruction is not. Beware too, of scarless mastectomies claims.
2. Breast reconstruction options for larger-framed women are improving. Now 3 of 10 women get nipple-sparing operations.
3. Expect more gene discoveries in the next year or two that identify the deadliest tumors needing more aggressive treatment for prostate, pancreatic and other cancers where hereditary plays a role.
4. Men need genetics testing too.

Summarized by Patricia Anstett, author, “Breast Cancer Surgery and Reconstruction: What’s Right for You,” from presentations at the conference of Facing Our Risk Empowered (FORCE).